Editor’s note: ESMO ASIA 2023 inaugurated its opening session, heralding a landmark event in the world of oncology. Hosted in the prestigious Hall 406, this congress brings together the brightest minds in cancer research and treatment, uniting a global community in the fight against this challenging disease. The opening ceremony featured the traditional Dragon Dance, symbolizing prosperity and health. This cultural performance underscored the congress’s commitment to diversity and inclusivity, setting a vibrant tone for the event. After the opening address, ESMO also commended society in Asia for their outstanding contributions in promoting international cooperation and exchanges. Dr. Donglu Zhao accepted the certificate of appreciation on behalf of the Chinese Society of Clinical Oncology (CSCO).
Opening Address
Dr. Andrés Cervantes, President of ESMO, opened the session with a powerful keynote lecture. His address, not only set the stage for the congress but also underscored the critical importance of international collaboration in advancing oncology research and patient care. He also said that Asia is an important part of the global fight against cancer. Asian oncologists are crucial to improving the survival time and quality of life of cancer patients in Asia and around the world. We hope to develop together with Asian oncology professionals and share the latest scientific and clinical advances in the field of oncology.
Scientific Co-Chairs Highlight the Congress Agenda
Dr. Brigette Ma, Scientific Co-Chair of the 2023 ESMO ASIA Congress, introduced the highlight projects of this conference, including:
New insights into the multifaced applications of liquid biopsies: from early detection and management of cancer to underpinning national screening programmes;
Asian studies in the expanding role of real-world data in oncology to obtaining insights on (rare) immune related toxicities;
Multimodal data integration for providing novel biomarker and personalised care in breast cancer;
Lifestyle changes, air pollution and screening programmes: what are the policy options to improve primary, secondary & tertiary cancer prevention in the Asia & Pacific region?
Token of Appreciation to Endorsing Societies
A special session from 09:45 AM to 10:05 AM was dedicated to recognizing the endorsing society representatives. This segment highlighted the collaborative spirit of the congress and expressed gratitude to the societies and contributors who have played a crucial role in bringing this event to fruition.
Dr. Andrés Cervantes, Chairman of the ESMO Congress, issued certificates of appreciation to oncology societies in Chinese mainland, Hong Kong, Taiwan, Indonesia, Pakistan, Iran and other Asian countries. Dr. Donglu Zhao, member of the Chinese Society of Clinical Oncology (CSCO) and Harbin Institute of Hematology and Oncology (HIHO), accepted the certificate of appreciation on behalf of CSCO.
Record-Breaking Participation and Diverse Sessions
The ESMO Asia Congress 2023 has marked a new record with over 3,368 participants from 69 countries. This unprecedented turnout reflects the global oncology community’s commitment to collaboration and knowledge sharing. The congress features a plethora of sessions, including more than 1,000 subject submissions encompassing 28 late-breaking abstracts, 634 abstracts for presentation, 22 Profit Papers, 74 mini-orals, and 506 posters.
Highlight sessions like the Aswell Women in Oncology Forum on gender equality, discussions on growth development in the Asia Pacific region, and policy debates for cancer prevention are set to generate insightful dialogues and action plans.
Global Representation and Future-Oriented Topics
This congress is not just a platform for sharing current scientific knowledge; it’s a forward-thinking summit that addresses the future of oncology. The program includes discussions on metastatic cancer, expert roundtables, and special sessions for Young Oncologists. These sessions are designed to cater to a diverse range of interests and expertise levels, ensuring that every participant finds value and opportunities for growth.
Dignitaries and representatives from various countries and oncological societies are in attendance, bringing a wealth of perspectives and experiences to the table. This diverse representation enhances the richness of discussions and the potential for groundbreaking collaborations.
Commitment to Education and Career Support
The ESMO Asia Congress 2023 is deeply committed to the education and professional development of oncologists. Initiatives such as the leaders generation program are designed to contextualize clinical practices for the Asian setting and beyond.
Advancing Global Cancer Care
The congress’s efforts extend beyond scientific discussions, aiming to influence policy and improve patient outcomes worldwide. The collaboration with the World Health Organization and the focus on universal health coverage in cancer care are testaments to this commitment.
As we proceed with the ESMO Asia Congress 2023, we anticipate a series of groundbreaking discussions, innovative research presentations, and strategic collaborations. This event is more than a conference; it’s a crucible for forging new paths in the global fight against cancer. We look forward to sharing further updates as the congress unfolds, confident that the outcomes of this event will significantly shape the future of oncology.
